ArthroCare to split stock in two-for-one deal:
This article was originally published in Clinica
ArthroCare, which markets devices based on its proprietary coblation technology, is to split its shares in a two-for-one deal, subject to shareholder approval. The Sunnyvale, California-based company has developed its radiofrequency ablation technology for a number of soft tissue surgery applications.
You may also be interested in...
Organizations like BARDA, CEPI and others are looking to partner with industry to rapidly test, manufacture, package and deploy vaccines and therapeutics, identifying areas they want to work together during BIO’s recent summit.
The economic stress on payers caused by the pandemic will cause a setback in the development of payment approaches for regenerative therapy, Blue Cross Blue Shield executive warns.
An interim final rule posted by the CMS this week widens further a series of telehealth exemptions and lab specimen collection payment provisions it has previously issued to help providers during the COVID-19 pandemic.